These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 17350694)

  • 1. The endocannabinoid system in targeting inflammatory neurodegenerative diseases.
    Centonze D; Finazzi-Agrò A; Bernardi G; Maccarrone M
    Trends Pharmacol Sci; 2007 Apr; 28(4):180-7. PubMed ID: 17350694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.
    Rossi S; Bernardi G; Centonze D
    Exp Neurol; 2010 Jul; 224(1):92-102. PubMed ID: 20353778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid system in neuropathological states.
    Orgado JM; Fernández-Ruiz J; Romero J
    Int Rev Psychiatry; 2009 Apr; 21(2):172-80. PubMed ID: 19367511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoid system in gp120-mediated insults and HIV-associated dementia.
    Bari M; Rapino C; Mozetic P; Maccarrone M
    Exp Neurol; 2010 Jul; 224(1):74-84. PubMed ID: 20353779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The brain as a target for inflammatory processes and neuroprotective strategies.
    Skaper SD
    Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis.
    Centonze D; Rossi S; Finazzi-Agrò A; Bernardi G; Maccarrone M
    Int Rev Neurobiol; 2007; 82():171-86. PubMed ID: 17678961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the endocannabinoid system: neuroprotection or neurotoxicity?
    Fowler CJ; Rojo ML; Rodriguez-Gaztelumendi A
    Exp Neurol; 2010 Jul; 224(1):37-47. PubMed ID: 20353772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of protein nitration in brain injury: a key pathophysiological mechanism in neurodegenerative, autoimmune, or inflammatory CNS diseases and stroke.
    Sarchielli P; Galli F; Floridi A; Floridi A; Gallai V
    Amino Acids; 2003 Dec; 25(3-4):427-36. PubMed ID: 14661102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid system: a new entry in remote cell death mechanisms.
    Viscomi MT; Oddi S; Latini L; Bisicchia E; Maccarrone M; Molinari M
    Exp Neurol; 2010 Jul; 224(1):56-65. PubMed ID: 20353775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in the nervous system--physiological and pathophysiological aspects.
    Schultzberg M; Lindberg C; Aronsson AF; Hjorth E; Spulber SD; Oprica M
    Physiol Behav; 2007 Sep; 92(1-2):121-8. PubMed ID: 17597167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the endocannabinoid system: to enhance or reduce?
    Di Marzo V
    Nat Rev Drug Discov; 2008 May; 7(5):438-55. PubMed ID: 18446159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of endocannabinoid system in physiological and pathological processes in the eye].
    Nadolska K; Goś R
    Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders.
    Heneka MT; Landreth GE; Hüll M
    Nat Clin Pract Neurol; 2007 Sep; 3(9):496-504. PubMed ID: 17805244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases.
    Maccarrone M; Battista N; Centonze D
    Prog Neurobiol; 2007 Apr; 81(5-6):349-79. PubMed ID: 17276576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammasome signaling at the heart of central nervous system pathology.
    Chakraborty S; Kaushik DK; Gupta M; Basu A
    J Neurosci Res; 2010 Jun; 88(8):1615-31. PubMed ID: 20127816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection from complement-mediated inflammatory damage.
    Kulkarni AP; Kellaway LA; Lahiri DK; Kotwal GJ
    Ann N Y Acad Sci; 2004 Dec; 1035():147-64. PubMed ID: 15681806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders.
    Bisogno T; Di Marzo V
    CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):564-73. PubMed ID: 20632970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polarised life of the endocannabinoid system in CNS development.
    Anavi-Goffer S; Mulder J
    Chembiochem; 2009 Jul; 10(10):1591-8. PubMed ID: 19533710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome.
    Storr MA; Yüce B; Andrews CN; Sharkey KA
    Neurogastroenterol Motil; 2008 Aug; 20(8):857-68. PubMed ID: 18710476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.